Bleomycin	2
survival aspects	2
ADVANTAGE	1
Two (qualifier value)	3
AOD use initiation	1
Pelvis	1
Financial cost	1
Methods	1
Upper arm	1
Cognitive function: initiation	1
Analysis	1
First (qualifier value)	1
Stillness (finding)	1
Continuance of life	2
Intravaginal (qualifier value)	1
milligram	1
Overall [Publication Type]	1
Disease-Free Survival	1
week (qualifier value)	1
day (qualifier value)	1
criteria	1
therapeutic aspects	3
Short (qualifier value)	1
Duration	1
Fourth (qualifier value)	1
Curved (qualifier value)	1
benefits	1
Likely	1
Longterm Effects	1
3	1
Toxicity aspects	1
One (qualifier value)	1
Attenuated by (contextual qualifier) (qualifier value)	1
Course (attribute)	1
Side (qualifier value)	1
Improving (qualifier value)	1
Cyclic (qualifier value)	2
Patients	7
adjuvant study	1
Potential	2
prediction	1
utilization	1
Pharmacotherapy	1
Improved (qualifier value)	2
Regional (qualifier value)	1
Additive (qualifier value)	1
Radiation therapy	1
Magnesium	1
Therapeutic procedure	4
More (qualifier value)	1
Research Personnel	1
Recurrence	1
recovery from disease	1
Malignant neoplasm of cervix uteri	1
statistical	1
Initial (qualifier value)	1
Uranium	1
Risk Factors	2
Equilibrium	1
Total hysterectomy (procedure)	1
Analysis of substances	1
Differential (qualifier value)	1
Arm	1
Clinical Trial, Phase III [Publication Type]	1
Third (qualifier value)	1
Toxic effect	1
Balanced - adjective	1
Chemotherapy-Oncologic Procedure	1
radiotherapeutic	1
pharmacotherapeutic	1
